ICAD (NASDAQ:ICAD) Adds US$15m to Market Cap in the Past 7 Days, Though Investors From Three Years Ago Are Still Down 82%
ICAD Highlights Global Availability of ProFound Cloud and International Expansion Milestones at JFR 2024
ICAD to Participate in the IAccess Alpha Buyside Best Ideas Fall Conference 2024
Lexaria Bioscience Taps InVivo Therapeutics CFO Richard Christopher As New CEO
The Market Lifts ICAD, Inc. (NASDAQ:ICAD) Shares 29% But It Can Do More
iCAD Inc | 10-Q/A: Quarterly report (Amendment)
iCAD Inc | 10-Q: Q2 2024 Earnings Report
Express News | Icad Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Revenue Results
BTIG Maintains ICAD Inc(ICAD.US) With Buy Rating, Maintains Target Price $3
Earnings Call Summary | ICAD Inc(ICAD.US) Q2 2024 Earnings Conference
Express News | Icad Q2 2024 GAAP EPS $(0.07), Inline, Sales $5.00M Beat $4.42M Estimate
Earnings Flash (ICAD) ICAD Reports Q2 Revenue $5M, Vs. Street Est of $4.4M
Earnings Flash (ICAD) ICAD Reports Q2 Loss $-0.07, Vs. Street Est of $-0.07
Express News | ICAD Inc - Believes It Has Sufficient Cash Resources to Fund Its Planned Operations With No Need to Raise Additional Funding
Express News | ICAD, Inc. Q2 Gross Profit USD 4.2 Million
Express News | ICAD, Inc. Q2 Operating Expenses USD 6.2 Million
Express News | ICAD, Inc. Q2 Revenue USD 5 Million
Express News | ICAD Reports Financial Results for Second Quarter Ended June 30, 2024
ICAD 2Q Loss $1.71M >ICAD
ICAD 2Q Loss/Shr 6c >ICAD